![](https://epimedresearch.com/wp-content/uploads/2023/01/brano-mm1vipqd0oa-unsplash.jpg)
Protecting and Advancing Great Ideas
Comprehensive Intellectual Property and FDA Compliance Solutions
![](https://epimedresearch.com/wp-content/uploads/2023/01/louis-reed-pwckf7l4-no-unsplash-1.jpg?w=1024)
FDA Regulatory Compliances
We help our client to navigate the complex regulatory landscape and achieve and maintain compliance with FDA regulations including assistance with drug development, approval, and manufacturing processes to ensure compliance with cGMP, assistance with food safety plans, labeling compliance, and facility planning to comply with the Food Safety Modernization Act (FSMA), and assistance with labeling requirements, ingredient safety, and cGMP compliance to comply with the Dietary Supplement Health and Education Act of 1994 (DSHEA).
![](https://epimedresearch.com/wp-content/uploads/2023/01/lycs-architecture-u2bi3gmnsse-unsplash.jpg?w=1024)
Intellectual Property Protection and Management
Our services include IP portfolio strategy and management, patentability search, patent drafting, filing, and persecution, patenting strategy, IP due diligence, IP landscape analysis, IP whitespace analysis, infringement searches and analysis, freedom-to-operate searches and analysis, and IP export control.
Keep Innovating, Keep Growing
The only way you survive is you continuously transform into something else. It’s this idea of continuous transformation that makes you an innovation company.
Learn more about the newest updates on intellectual property law and life sciences at our BLOG
We help to protect your most valuable assets
![](https://wpcomverticals.files.wordpress.com/2022/05/pexels-pixabay-256262.jpg?resize=2000%2C1333)
Biotechnology and Life Sciences
Antibodies, antibody-conjugates, antibody therapeutics, proteins, gene therapy, proteomics, genomics, molecular biology, plant and animal genetics
![](https://epimedresearch.com/wp-content/uploads/2023/01/hans-reniers-lqgjcmy5qcm-unsplash.jpg?w=1024)
Chemistry and Material Sciences
Small molecules, polymers, polymer conjugates, nanotechnology, natural product chemistry, synthetic chemistry, pharmaceutical chemistry, combinatorial chemistry
![](https://epimedresearch.com/wp-content/uploads/2023/01/terry-vlisidis-rflgrtzu3cw-unsplash.jpg?w=1024)
Pharmaceutics and Medical Technology
Drug discovery, novel chemical entities, antibody therapy, immunology, pharmaceutical compositions, methods of treating, method of diagnosis; Bioinformatics, diagnostic assays, medical devices, analytical devices, medical imaging and display
![](https://epimedresearch.com/wp-content/uploads/2024/02/maria-kozyr-kqbx7ytcguc-unsplash.jpg?w=1024)
Functional food and beverage compositions, novel supplement or nutritional ingredients and composition, method of making, method of using; FDA compliance issues in manufacturing, storage, distribution, quality control, and label claims.
ABOUT US
EpiMed Research provides a full range of services that support our clients’ intellectual property and FDA compliance needs.
We help our clients to secure, protect and advance Intellectual Property (IP) rights by performing technology scouting and acquisition, technology due diligence, patentability search, patenting strategy, patent application preparation, drafting, filing and persecution, IP due diligence, IP landscape analysis, IP whitespace analysis, patent infringement searches and analysis, freedom-to-operate searches and analysis, and IP portfolio strategy and management services.
Our team includes scientists, engineers, patent attorneys, and regulatory experts with experiences in prestigious academic institutions, large fortune 500 companies, and law firms. Diversely experienced in scientific, business, and legal fields, our team researched novel therapeutics in both academic and industrial labs, advised clients from blue-chip pharmaceutical companies to biotech startups and several have previously co-founded companies as entrepreneurs.
Our clients range from technology companies, research institutions, scientific publication agencies, and venture capital firms, to private equity investment groups.